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AcetylcholineThe role of the acetylcholine-mediated system in the organization of postictal antinociception was
investigated. For this purpose, nicotinic and muscarinic cholinergic receptor antagonists were microinjected
into the nucleus raphe magnus (NRM), a key structure of the endogenous pain inhibitory system. After the
tail-ﬂick test baseline recording, maleWistar rats (N=8 per group) were submitted to stereotaxic surgery for
the introduction of a guide cannula aiming at the NRM. Five days after surgery, atropine or mecamylamine
(1 µg/0.2 µL, 3 µg/0.2 µL, or 5 µg/0.2 µL) was microinjected into the NRM. The tail-ﬂick withdrawal latency
was recorded immediately after peripheral treatment with pentylenetetrazole (PTZ) (64 mg/kg), in two
different interictal time windows, and for 130 minutes after the last seizure evoked by intraperitoneal
injection of PTZ. The blockade of GABA-mediated Cl– inﬂux caused tonic–clonic convulsions in all animals
followed by sustained postictal antinociception lasting 110 minutes after seizures; the nociceptive threshold
was also found to be high in interictal periods. Pretreatment of the NRM with either atropine or
mecamylamine antagonized both interictal and postictal antinociception, suggesting the involvement of
cholinergic mechanisms recruiting muscarinic and nicotinic cholinergic receptors of the NRM in the
organization of tonic–clonic seizure-induced antinociception.atomia & Neuropsicobiologia,
icina de Ribeirão Preto da
eirantes, 3900, Ribeirão Preto
a).
vier OA license.© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Several investigations have been performed to elucidate the
neuroanatomical and neurochemical bases of analgesia and the neural
substrates involved in epileptic activity [1–9].
The postictal state is an immediate consequence of seizures [10], in
which it is possible to detect oscillations of nociceptive thresholds
[11–15]. It has been observed that during the postictal state, patients
experience delusions, agitation, aggressive behavior [7], and cognitive
symptoms such as attentional deﬁcits and concentration impairments
[8]. Paresis may also occur, signaling the location of seizures in the
contralateral motor cortex [10].
Previous studies have demonstrated antinociceptive processes
in experimental models of epilepsy in both human- [16] and animal
[11,12]-based models. Among several approaches used in experimen-
tal neurology to induce seizures, the pharmacological model of
epilepsy using pentylenetetrazole (PTZ), a GABAergic noncompetitive
antagonist that does not interact directly with GABA receptors, butblocks GABA-mediated Cl– inﬂux, is used widely [2,17]. The intraper-
itoneal injectionof PTZ in rats causes tonic–clonic seizures consistently
followed by increases in the nociceptive threshold [5,18–22].
Mesencephalic structures, such as the periaqueductal gray matter
(PAG) and nuclei of the ventromedial medulla oblongata, in particular
the nucleus raphe magnus (NRM), have been suggested to play
important roles in the control of supraspinal pain [1,23]. However,
other nuclei of the endogenous pain inhibitory system, such as the
dorsal raphe nucleus, rich in serotonin, and also the locus coeruleus,
an important noradrenergic nucleus of the brainstem, have been
implicated in tonic–clonic seizure-induced antinociception [24,25].
The ﬁrst evidence suggesting involvement of the NRM in postictal
analgesia was demonstrated by neurochemical damage of the NRM
resulting in a signiﬁcant decrease in postictal antinociception [3].
Raphe–spinal pathways originating in the NRM reach the gelatinous
substance of the spinal cord, inhibiting noxious inputs. Previous
evidence has demonstrated that muscarinic and nicotinic receptors
are involved in the control of perception of nociceptive stimuli in both
animal trials and human models of pain [6,26].
Published reports have described the involvement of endogenous
opioid receptors [11,12] in hypoalgesic processes following seizures.
The organization of postictal antinociception may involve a μ1-opioid
receptor-mediated mechanism in the central nucleus of the inferior
colliculus [24], an endocannabinoid-mediated system of the
Table 1
Severity scale of generalized tonic–clonic convulsive reactions induced by intraperi-
toneal administration of PTZ (64 mg/kg), according to Racine's index of severity [34],
later modiﬁed by R.L. de Freitas [20].
Score Seizing reaction
0.0 Exploratory behavior
1.0 Jaw and/or facial myoclonic action
Short-duration anterior paw myoclonus
2.0 Head myoclonia
Moderate myoclonia of anterior paws with duration of at least 5 s
3.0 Anterior limb tonic extension
Anterior paw severe myoclonia with duration of at least 10 s
4.0 Complete tonic extension
Rearing and severe myoclonia of anterior paw
5.0 Complete tonic extension
Rearing and falling, myoclonia of anterior and posterior paws
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system involving both the dorsal raphe nucleus [5] and the reticularis
gigantocellularis/paragigantocellularis nuclei [3]. There is also evi-
dence that acetylcholine may be involved as a neurotransmitter in
postictal analgesia, suggesting a critical role for muscarinic and
nicotinic cholinergic receptors in the organization of this interesting
antinociceptive process [20].
In fact, both cholinergic and noradrenergic inputs to the NRM have
been described to exert a remarkable role in the modulation of pain
[9,27]. In addition, another report provided evidence that there is
an excitatory connection between the PAG and the NRM. The results
indicate that activation of this pathway can induce analgesia [28].
Acetylcholine is an excitatory neural transmitter at the NRM [27],
and ﬁndings suggest there is another brainstem structure that sends
inputs to the NRM [29]: the pedunculopontine tegmental nucleus,
rich in choline acetyltransferase-containing neurons [19,28–32].
Therefore, the present study investigated the role of cholinergic
mechanisms of the NRM in the elaboration of interictal and postictal
antinociceptive processes that follow seizures caused by the systemic
GABAergic dysfunction induced by PTZ.
2. Methods
2.1. Subjects
Male Wistar albino rats (N=8 per group), weighing between
200 and 250 g, from the animal care facility of the Campus
Universitarius of the University of São Paulo (USP) in Ribeirão
Preto were used. These animals were housed in groups of four in a
plexiglass-walled cage, with free access to food and water
throughout the experiment. The room temperature was controlled
(22±1 °C), and a light/dark cycle (07:00–19:00 hours lights on)
was maintained. All protocols were used in compliance with the
recommendations of the Brazilian Society for Neuroscience and
Behaviour (SBNeC), as well as with the recommendations of the
Committee for Ethics in Animal Experimentation (CEUA) of the
Ribeirão Preto Medical School of the University of São Paulo
(FMRP-USP) (Proc. 174/2005), which are in accordance with the
Animal Research Ethics guidelines adopted by the Brazilian College
of Animal Experimentation (COBEA).
2.2. Stereotaxic surgery
The animals were anesthetized with sodium pentobarbital
(45 mg/kg, ip) and ﬁxed in a stereotaxic frame (David Kopf, USA).
A stainless-steel guide cannula (o.d. 0.6 mm, i.d. 0.4 mm) was
implanted in the brainstem, aimed at the NRM. The upper incisor
bar was set 3.3 mm below the interaural line such that the skull was
horizontal between the bregma and lambda landmarks. The guide
cannula was vertically introduced using the following coordinates,
with the bregma serving as the reference for each plane: anteropos-
terior, −10.5 mm; mediolateral, 0.0 mm; dorsoventral, 9.2 mm. The
guide cannula was ﬁxed to the skull by means of acrylic resin and two
stainless-steel screws. At the end of the surgery, each guide cannula
was sealed with a stainless-steel wire to protect it from obstruction.
After the surgery, each animal was treated with an intramuscular
injection of 60.000 IU of penicillin G benzathine and a nonsteroidal
anti-inﬂammatory drug (banamine meglumine at 2.5 mg/kg).
2.3. Nociceptive tests
Eachanimalwas individually placed in a restraining apparatus, and its
tail was inserted into a heating sensor (tail-ﬂick Analgesia Instrument;
Stoelting, IL, USA). The heating sensor functions such that calorimetric
progressive elevation is automatically interrupted at the moment when
the animal removes its tail from the apparatus. The current raises thetemperature of the coil (Ni/Cr alloy, 26.04 cm in length×0.02 cm in
diameter) from room temperature (approximately 20 °C) at the rate of
9 °C/second [33]. A small current intensity adjustment could be
performed at the beginning of the experiment to obtain three
consecutive tail-ﬂick latencies (TFLs) between 2.5 and 3.5 seconds. If
the animal did not remove its tail from the heater within 6 seconds, the
tail-ﬂick device was turned off to prevent damage to the skin. Baseline
tail-ﬂick test measurements were obtained before stereotaxic surgery.
Three baseline measurements of control TFLs were taken at
5-minute intervals. Animals (independent groups) received central
microinjections of saline, atropine, or mecamylamine at different
concentrations (1 μg/0.2 μL, 3 μg/0.2 μL and 5 μg/0.2 μL) in the NRM
(n=8); after 5 minutes animals received an intraperitoneal injection
of PTZ (64 mg/kg). Nociceptive thresholds were recorded before
and after peripheral or central injections of drugs, immediately after
the last incidence of tonic–clonic seizures (time zero), and subsequently
at 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, and 130 minutes
after seizure induction by PTZ.
Independent groups of animals were submitted to tests to determine
the potential intrinsic effect of each pharmacological pretreatment of the
NRM with atropine or mecamylamine followed by intraperitoneal
treatment with physiological saline on nociceptive thresholds.
The effect of pretreatment of the NRMwith atropine,mecamylamine,
or physiological saline followedby intraperitoneal treatmentwith PTZon
interictal oscillation of the nociceptive thresholds was also investigated.
Finally, a sham procedure was performed in an independent group
of rodents. This sham procedure consisted of the introduction of an
injector needle inside the guide cannula inserted into the NRM
without subsequent microinjections of cholinergic pharmacological
antagonists or vehicle.
2.4. Behavioral test
Animals were placed in a circular arena with walls made of
transparent acrylic, which measured 60 cm in diameter and 50 cm in
height. This apparatus was located in an experimental compartment
and was illuminated by a ﬂuorescent lamp (350 lx at the arena ﬂoor
level). Evaluation of the effects of drug administration (PTZ, atropine,
mecamylamine, and physiological saline) was performed while rats
were inside the arena.
The tonic–clonic convulsive reactions induced by PTZ were the
motor parameters used to evaluate the effect of GABA-mediated Cl–
inﬂux blockade. Latency to seizures was deﬁned as the time from
injection of PTZ to the ﬁrst evidence of anterior pawmyoclonia, which
is considered as the ﬁrst evidence of seizure onset. The frequency
and severity of seizures (according to Racine's index [34] as modiﬁed
later by de Freitas [20]) during the convulsive process caused by
intraperitoneal administration of PTZ were also recorded, as indicated
in Table 1.
Fig. 1. A: Schematic representation of histologically conﬁrmed sites of atropine
microinjections at 1 μg/0.2μL (△), 3 μg/0.2 μL (●) and 5 μg/0.2 μL (○), sham procedure
(□) andmicroinjections of physiological saline (▲) in the nucleus raphemagnus (NRM)
followed by intraperitoneal (IP) treatment with pentylenetetrazole (PTZ) depicted in
anagrams based on the atlas by Paxinos and Watson [36]. B: Schematic representation
of histologically conﬁrmed sites of microinjection of mecamylamine at 1 μg/0.2 μL (△),
3 μg/0.2 μL (●) and 5 μg/0.2 μL (○), sham procedure (□) and microinjections of
physiological saline (▲) in the NRM followed by IP treatment with PTZ, depicted in
anagrams based on the atlas by Paxinos and Watson [36]. C: Schematic representation
of histologically conﬁrmed sites of the sham procedure (□) and pretreatment of the
NRM with microinjections of atropine at 5 μg/0.2 μL (●), mecamylamine at 5 μg/0.2 μL
(○), and physiological saline (▲) followed by IP treatment with physiological saline,
depicted in anagrams based on the atlas by Paxinos and Watson [36].
Fig. 2. Effect of microinjections of atropine (1 μg/0.2 μL, 3 μg/0.2 μL and 5 μg/0.2 μL) in the
nucleus raphe magnus (NRM) (N=8) on postictal antinociception. Data were presented as
mean SEM. *, statistically signiﬁcant differences (pb0.05), as comparedwith the saline (NaCl
0.9%)-NRMpretreatment followedby intraperitoneal (IP) treatmentwithphysiological saline
group;#, statistically signiﬁcantdifferences (pb0.05) as comparedwith theNRMsaline (NaCl
0.9%)-pretreatment followed by IP treatment with pentylenetetrazole (PTZ) (64 mg/kg)
group; +, statistically signiﬁcant differences (pb0.05) compared to the sham procedure in
the NRM followed by IP treatment with PTZ (64mg/kg) group; §, statistically signiﬁcant
differences (pb0.05) compared to theNRMatropine at 1 μg/0.2 μL-pretreatment followed by
IP treatment with PTZ (64mg/kg) group; X, statistically signiﬁcant differences (pb0.05) as
comparedwith NRMatropine at 3 μg/0.2 μL-pretreatment followed by IP treatmentwith PTZ
(64mg/kg) group; &, statistically signiﬁcant differences (pb0.05) as compared with NRM
atropine at 5 μg/0.2 μL-pretreatment followed by IP treatment with PTZ (64mg/kg) group,
according to repeated measure ANOVA, followed by Duncan´s post hoc test.
Fig. 3. Effect ofmicroinjections ofmecamylamine (1 μg/0.2 μL, 3 μg/0.2 μL and 5 μg/0.2 μL)
in the NRM (N=8) on postictal antinociception. Data were presented as mean SEM. *,
statistically signiﬁcantdifferences (pb0.05), as comparedwith the saline (NaCl0.9%)-NRM
pretreatment followed by intraperitoneal (IP) treatment with physiological saline group;
#, statistically signiﬁcant differences (pb0.05) as compared with the NRM saline (NaCl
0.9%)-pretreatment followed by IP treatment with pentylenetetrazole (PTZ) (64 mg/kg)
group; +, statistically signiﬁcant differences (pb0.05) as compared with the sham
procedure in the NRM followed by IP treatmentwith PTZ (64 mg/kg) group; §, statistically
signiﬁcant differences (pb0.05) as compared to the NRM mecamylamine at 1 μg/0.2 μL-
pretreatment followed by IP treatment with PTZ (64 mg/kg) group; X, statistically
signiﬁcant differences (pb0.05) as comparedwith theNRMmecamylamine at 3 μg/0.2 μL-
pretreatment followed by IP treatment with PTZ (64 mg/kg) group; &, statistically
signiﬁcant differences (pb0.05) as compared with NRM mecamylamine at 5 μg/0.2 μL-
pretreatment followedby IP treatmentwith PTZ (64 mg/kg) group, according to repeated-
measurement ANOVA, followed by Duncan´s post-hoc test.
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Pentylenetetrazole (64 mg/kg), atropine, andmecamylaminewere
from Sigma/Aldrich, St. Louis, MO, USA. Each cholinergic antagonist
was dissolved in physiological saline (NaCl 0.9%) shortly beforeadministration and administered at the following concentrations:
1 μg/0.2 μL, 3 μg/0.2 μL, and 5 μg/0.2 μL. Physiological saline was used
as the control.
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After testing, the rats were anesthetized with sodium pentobar-
bital (45 mg/kg, ip) and perfused via the left ventricle. The blood was
washed out with cold, oxygen-enriched, Ca2+-free Tyrode's buffer
(40 mL at 4 °C), followed by 200 mL of ice-cold 4% (w/v) paraformal-
dehyde in 0.1 M sodium phosphate buffer, pH 7.3, for 15 minutes
at a pressure of 50 mm Hg. The brainstem was quickly sectioned,
removed, and immersed in fresh ﬁxative for 4 hours at 4 °C. It was
then rinsed in 10 and 20% sucrose dissolved in 0.1 M sodium
phosphate buffer (pH 7.4) at 4 °C, for at least 12 hours in each
solution. Tissue pieces were immersed in 2-methylbutane (Sigma),
frozen on dry ice, embedded in Tissue Tek OCT, and cut with a cryostat
(CM 1950 Leica) at −22 °C. Sections were then mounted on glass
slides coated with chrome alum gelatin to prevent detachment
and stained with haematoxylin–eosin (LEICA Autostainer XL, CV
5030) to be viewed on a photomicroscope (AxioImager Z1, Zeiss).
Statistical analysis was performed exclusively with data from the
animals that presented signs that microinjection into the NRM had
been successful.Fig. 4. A: Lack of effect of NRM pretreatment with physiological saline (N=7), NRM sha
mecamylamine at 5 μg/0.2 μL-pretreated group (N=7), followed by IP administration of p
reﬂexes in the tail-ﬂick test. Data were presented as mean±SEM. PN0.05 in all cases, acc
represent the stereotaxic surgery, in B the administration of cholinergic antagonists and
physiological saline 5min after each NRM pretreatment. B: Lack of effect of the sham proced
thresholds, according to Student's Wilcoxon test. Columns represent means; bars represent2.7. Analysis of results
Data from experiments investigating the effect of cholinergic
receptor blockade in the NRM on TFLs and interictal and postictal
antinociception were submitted to repeated-measures analysis of
variance (ANOVA). In the case of a signiﬁcant treatment×time
interaction, one-way ANOVA was performed at each time interval,
followed by Duncan's post hoc test. Comparisons between tail-
ﬂick baseline values and TFLs recorded immediately after each
pharmacological pretreatment of the NRM and those recorded
before intraperitoneal treatment with PTZ were analyzed with
Wilcoxon's test. Pb0.05 was indicative of statistically signiﬁcant
differences.3. Results
Pentylenetetrazole induced severe tonic–clonic seizures in all
animals, followed by a sustained increase in the nociceptive threshold
lasting 110 minutes after convulsive reactions, and these reactionsm procedure (N=6), NRM atropine at 5 μg/0.2 μL-pretreated group (N=7) or NRM
hysiological saline on the nociceptive thresholds, which were recorded as withdrawal
ording to repeated measure ANOVA, followed by Duncan´s post hoc test. Arrows in A
physiological saline in the ventromedial medulla, and in C the IP administration of
ure, atropine, mecamylamine or physiological pretreatment of the NRM on nociceptive
SEM.
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inside the NRM (Figs. 1A, B and C).
Microinjections of atropine (1 μg/0.2 μL, 3 μg/0.2 μL, and 5 μg/0.2 μL)
into the NRM (Fig. 1A) decreased postictal antinociception. Signiﬁcant
effects of treatment [F(5,40)=15.27, Pb0.001], time [F(14,27)=40.07,
Pb0.001], and the treatment×time interaction [F(70,127)=3.18,
Pb0.001] were observed. Repeated-measures ANOVA revealed a
signiﬁcant effect of NRM pretreatment with the cholinergic muscarinic
receptor antagonist atropine from 0 to 130 minutes [F(5,40) varying
from 1.21 to 17.77, Pb0.05]. Post hoc analyses showed that microinjec-
tions of atropine into the NRM decreased the postictal analgesia
recorded immediately after the seizure and 10 to 100 minutes after
convulsive reactions (Duncan´s post hoc test, Pb0.05 in all cases)
(Fig. 2).
Microinjections of mecamylamine (1 μg/0.2 μL, 3 μg/0.2 μL, and
5 μg/0.2 μL) into the NRM (Fig. 1B) also decreased the phenomenon
of tonic–clonic seizure-induced antinociception. Statistical analysis
revealed signiﬁcant effects of treatment [F(5,40)=12.71, Pb0.001],
time [F(14,27)=34.09, Pb0.001], and the treatment×time inter-
action [F(70,127)=2.11, Pb0.001]. Repeated-measures ANOVA
showed a signiﬁcant effect of NRM pretreatment with the
cholinergic nicotinic receptor antagonist mecamylamine on post-
ictal analgesia from 0 to 130 minutes [F(5,40) varying from 0.81 to
15.82, Pb0.05]. Post hoc analyses showed that microinjections of
mecamylamine into the NRM caused a decrease in the postictal
analgesia recorded immediately after convulsive responses and
from 10 to 70 minutes after seizures (Duncan's post hoc test,
Pb0.05), as shown in Fig. 3.
Interictal oscillations of nociceptive thresholds were observed to
increase in height after convulsive reactions caused by PTZ. Pretreat-
ment of the NRM with atropine or mecamylamine (5 μg/0.2 μL)
also antagonized interictal antinociception, which was most pro-
nounced in later interictal measurements. There were signiﬁcant
effects of treatment [F(3,23)=15.34, Pb0.001], time [F(3,21)=24.01,
Pb0.001], and the treatment×time interaction [F(9,59)=6.33,
Pb0.001]. Repeated-measures ANOVA revealed a signiﬁcant effect of
NRM pretreatment with cholinergic muscarinic and nicotinic receptor
antagonists on interictal antinociception [F(3,23) varying from 4.24Fig. 5. Effect of NRM pretreatment with physiological saline (N=7), atropine (5 μg/0.2 μL) (N
the interictal antinociception recorded twice after IP treatment with PTZ, and lack of effe
physiological saline on tail-ﬂick latencies. Data are presented as mean SEM. *, statistically
group + IP treatment with physiological saline; #, statistically signiﬁcant differences (pb0.0
PTZ, according to repeated-measure ANOVA, followed by Duncan´s post-hoc test. Column
nociceptive threshold. BL: average baseline values.to 17.31, Pb0.05]. Post hoc analyses showed that microinjections
of atropine or mecamylamine into the NRM decreased interictal
analgesia, especially during the later interictal period (Duncan´s post
hoc test, Pb0.05 in all cases) (Fig. 5).
Pharmacological treatment of the NRM with atropine or
mecamylamine (5 μg/0.2 μL) had no statistically signiﬁcant intrinsic
effect on nociceptive thresholds, as shown in Fig. 4A. Repeated-
measures ANOVA showed no signiﬁcant effect of either treatment [F
(3,22)=0.30, PN0.05], time [F(20,3)=1.24, PN0.05], or the treat-
ment×time interaction [F(60,5)=2.1, PN0.05]. Repeated-measures
ANOVA did not reveal signiﬁcant differences of NRM pretreatment
with either atropine or mecamylamine 5 minutes before intraperito-
neal administration of physiological saline, as determined by consec-
utive recordings from 0 to 130 minutes of withdrawal reﬂex latencies
[F(3,23) varying from 0.13 to 5.63, PN0.05].
In addition, the different pharmacological treatments of the NRM
with atropine (Figs. 6A, B and C) and mecamylamine (Figs. 7A, B
and C) had no statistically signiﬁcant effects on the tail-ﬂick baseline
curve (Fig. 4B), the duration of or latency to pharmacologically
induced seizures, or the severity or frequency of convulsive reactions,
according to Racine’s index of severity [34] as modiﬁed later by R.L. de
Freitas [20], during the convulsive responses caused by intraperito-
neal administration of PTZ (Duncan’ s post hoc test, PN0.05 in all
cases).
4. Discussion
The present ﬁndings suggest the participation of muscarinic
receptors of NRM neurons in both interictal and postictal analgesia. It
was found that atropine decreases postictal antinociception immedi-
ately after the end of seizures until 100 minutes after convulsions, in
a dose-dependent manner at 10 minutes after seizure. Atropine also
induced a decrease in the interictal antinociception in at least
two different time windows following the pharmacological induction
of seizures with PTZ.
This ﬁnding was corroborated by pretreatment of the NRM
with mecamylamine, which resulted in an expressive antago-
nism of the postictal antinociception similar to that caused by=7), or mecamylamine (5 μg/0.2 μL) (N=7), on nociceptive baseline threshold and on
ct of the NRM pretreatment with physiological saline (N=6) plus IP treatment with
signiﬁcant differences (pb0.05) as compared with NRM saline (NaCl 0.9%)-pretreated
5) as compared with the NRM saline (NaCl 0.9%)-pretreated group + IP treatment with
s represent mean nociceptive threshold (NT); bars represent the SEM. INT: interictal
Fig. 6. A: Effect of nucleus raphe magnus (NRM) pretreatment with physiological saline + intraperitoneal (IP) treatment with pentylenetetrazole (PTZ) (64 mg/kg)
(N=8); NRM-pretreatment with atropine at 1 µg/0.2 µL + IP PTZ (64mg/kg) (N=8); NRM-pretreatment with atropine at 3 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) and
NRM-pretreatment with atropine at 5 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) on the latency and duration of tonic–clonic seizures. B: Effect of NRM pretreatment with
physiological saline + IP PTZ (64mg/kg) (N=8); NRM-pretreatment with atropine at 1 µg/0.2 µL + IP PTZ (64mg/kg) (N=8); NRM-pretreatment with atropine at
3 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) and NRM-pretreatment with atropine at 5 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) on the frequency of tonic–clonic seizures.
C: The effect of NRM pretreatment with physiological saline + IP PTZ (64mg/kg) (N=8); NRM-pretreatment with atropine at 1 µg/0.2 µL + IP PTZ (64mg/kg)
(N=8); NRM-pretreatment with atropine at 3 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) and NRM-pretreatment with atropine at 5 µg/0.2 µL + IP PTZ (64mg/kg) (N=8)
on the severity of tonic–clonic seizures.
183R.C. de Oliveira et al. / Epilepsy & Behavior 22 (2011) 178–185pretreatment of the NRM with atropine. Mecamylamine-pre-
treated animals exhibited a dose-dependent effect from 0 to
40 minutes after seizure onset. In addition, the blockade of
cholinergic nicotinic receptors in the NRM also decreased the
interictal antinociception recorded in a late time window period
among seizures caused by the peripheral blockade of GABA-
mediated Cl– inﬂux.
There was no intrinsic effect of pretreatment of the NRM with
cholinergic antagonists, considering that pretreatment of the NRM
with atropine or mecamylamine failed to alter baseline TFLs or the
severity, duration, latency, or frequency of convulsive seizures,in comparison to controls. In addition, central administration of
atropine or mecamylamine into the NRM at the highest concentration
(5 μg/0.2 μL), followed by intraperitoneal treatment with physiolog-
ical saline, did not have a statistically signiﬁcant effect on baseline
nociceptive thresholds.
Previous studies have reported that a lesion in the NRM
signiﬁcantly decreases the increase in nociceptive threshold caused
by tonic–clonic seizures [3]. A similar effect was observed with
respect to the analgesia induced bymorphine after lesions to the NRM
[18,35]. However, we cannot rule out the involvement of other
cholinergic neuron- and cholinergic ﬁber-containing structures of the
Fig. 7. A: Effect of nucleus raphe magnus (NRM) pretreatment with physiological saline + intraperitoneal (IP) treatment with pentylenetetrazole (PTZ) (64mg/kg) (N=8); NRM-
pretreatment with mecamylamine at 1 µg/0.2 µL + IP PTZ (64mg/kg) (N=8); NRM-pretreatment with mecamylamine at 3 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) and NRM-
pretreatment with mecamylamine at 5 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) on the severity of tonic–clonic seizures. B: Effect of NRM pretreatment with physiological saline + IP
PTZ (64mg/kg) (N=8); NRM-pretreatment with mecamylamine at 1 µg/0.2 µL + IP PTZ (64mg/kg) (N=8); NRM-pretreatment with mecamylamine at 3 µg/0.2 µL + IP PTZ
(64mg/kg) (N=8) and NRM-pretreatment with mecamylamine at 5 µg/0.2 µL+ IP PTZ (64mg/kg) (N=8) on the frequency of tonic–clonic seizures. C: Effect of NRM pretreatment
with physiological saline + IP PTZ (64mg/kg) (N=8); NRM-pretreatment with mecamylamine at 1 µg/0.2 µL+ IP PTZ (64mg/kg) (N=8); NRM-pretreatment with mecamylamine
at 3 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) and NRM-pretreatment with mecamylamine at 5 µg/0.2 µL + IP PTZ (64mg/kg) (N=8) on the latency and duration of tonic–clonic
seizures.
184 R.C. de Oliveira et al. / Epilepsy & Behavior 22 (2011) 178–185brainstem, such as the pedunculopontine tegmental nucleus, the
periaqueductal gray matter, or serotonergic neurons of the dorsal
raphe nucleus in the organization of postictal analgesia.
The role of serotoninergic receptors in this antinociceptive
phenomenon is already known [3]; however, this is the ﬁrst time in
which participation of muscarinic and nicotinic receptors of the NRM
in elaboration of interictal and postictal antinociception has been
demonstrated. It is possible that involvement of the cholinergic
system in interictal and postictal antinociception is based on the
control of activity of serotonergic neurons of the NRM that sendoutput to the secondary ascending neurons of the spinal cord and
trigeminal spinalis nucleus.
Previous studies have used peripheral administration of choliner-
gic antagonists to demonstrate involvement of the cholinergic
systems in the analgesia induced by convulsive reactions [20],
suggesting that acetylcholine is released at the synaptic connection
of neural networks responsible for the elaboration of postictal
analgesia, in the early stages of the antinociceptive phenomenon.
However, serotonin and noradrenaline are critically released in later
periods of postictal analgesia [21]. Ascending cholinergic pathways
185R.C. de Oliveira et al. / Epilepsy & Behavior 22 (2011) 178–185from the pedunculopontine tegmental nucleus, with synaptic targets
in the dorsal raphe nucleus, and cholinergic pathways descending
toward the NRM and locus coeruleus appear to play an important role
in the postictal antinociceptive phenomenon [29].
In conclusion, the data described here show that cholinergic
nicotinic and muscarinic receptor antagonists administered into the
NRM cause long-lasting blockade of the antinociception induced
by tonic–clonic seizures, demonstrating the relevance of cholinergic
inputs to the NRM in the modulation of postictal antinociception.
Therefore, the present work takes an additional step in this important
line of research, demonstrating the involvement of NRM neurons
in the organization of both interictal and postictal antinociception.
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